Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine for Emergence Agitation in Preschool Children Undergoing Otolaryngologic Surgery
ChiCTR2500114207Phase 4Not yet recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Dec 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of nalbuphine in Emergence agitation (EA) (2 arms), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: Pediatric Anesthesia Emergence Delirium Score (PAED). Planned start Dec 2025; status: not yet recruiting.
02
Drugs
nalbuphine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on ChiCTR2500114207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500114207.